DAFTAR PUSTAKA:
1. Znaor A, Lortet-Tieulent J, Jemal A, Bray F. International variations and trends in testicular cancer incidence and mortality. Eur. Urol.
2014;65(6):1095-106. doi:10.1016/j.eururo.2013.11.004.
2. Mcglynn KA, Cook MB. Etiologic Factors in Testicular Germ Cell Tumor. Natl. Inst. Heal. 2010;5(9):1389-1402. doi:10.2217/fon.09.116.Etiologic.
3. Nieschlag E, Behre HM, Nieschlag S. Andrology:Male Reproductive Health and Dysfunction. Berlin, Heidelberg: Springer Berlin Heidelberg; 2010. doi:10.1007/978-3-540-78355-8.
4. Huyghe E, Plante P, Thonneau PF. Testicular Cancer Variations in Time and Space in Europe. Eur. Urol. 2007;51(3):621-628.
doi:http://dx.doi.org/10.1016/j.eururo.2006.08.024.
5. Svechnikov K, Izzo G, Landreh L, Weisser J, Söder O. Endocrine disruptors and Leydig cell function. J. Biomed. Biotechnol. 2010;2010.
doi:10.1155/2010/684504.
6. Virtanen HE, Adamsson A. Cryptorchidism and endocrine disrupting chemicals. Mol. Cell. Endocrinol. 2012;355(2):208-20.
doi:10.1016/j.mce.2011.11.015.
7. Hejmej A, Kotula-balak M, Bili B. Antiandrogenic and Estrogenic
Compounds : Effect on Development and Function of Male Reproductive
System. 2009.
8. Pamela R. Reproductive Health Effects of Pesticide Exposure Issues for Farmworker. 2008:1-28.
9. Children ’ s Health and the Environment. WHO 2008.
10. Abhilash PC, Singh N. Pesticide use and application : An Indian scenario. 2009;165:1-12. doi:10.1016/j.jhazmat.2008.10.061.
51
12. Fowler K a, Gill K, Kirma N, Dillehay DL, Tekmal RR. Overexpression of Aromatase Leads to Development of Testicular Leydig Cell Tumors:An in Vivo Model for Hormone-Mediated Testicular Cancer. 2000;156(1):347-353.
13. Tannenbaum M, F.Madden J, eds. Diagnostic Atlas of Genitourinary Pathology. Curchill Livingstone Elsevier; 2006.
14. Setiawan FE. Pengaruh Paparan Obat Nyamuk Terhadap Gambaran Histologi Sel Leydig Tikus Sprague Dawley. 2014.
15. Winarni TI. Alteration of Rat Reproductive Organ in Adulhood Caused by the Exposure of Foreign Estrogenic Compounds (Mosquito Insecticides During Early Life). 2004.
16. Sadler T. Langman: Embriologi Kedokteran. 10th ed. Jakarta: EGC; 2009.
17. McCane KL, E.Huether S. Pathophysiology:The Biologic Basis for Disease in Adults and Children. 5th ed. St. Louis, Missouri: Elsevier Mosby; 2006.
18. American Cancer Society. Testicular Cancer What is cancer ? 2014.
19. Standring S, ed. Grays Anatomy: The Anatomical Basis of Clnical Practice. 39th ed. Elsevier CHurchill Livingstone; 2005:1305-1310.
20. Marieb EN. Human Anatomy and Physiology. 5th ed. Benjamin Cummings; 2001:1072-1073.
21. E.Mills S, ed. Histology for Pathologists. 4th ed. China: Wolters Kluwer Health; 2012.
22. Andrology: Male Reproductive Health and Dysfunction. 2nd ed. New York: Springer; 2000.
23. L.Mescher A. Junqueira’s Basic Histology: Text and Atlas.
24. Cui D. Atlas of Histology with Functional and Clinical Correlation. Wolters Kluwer Health; 2011:347.
52
26. Wein AJ. Campbell-Walsh Urology. 10th ed. Philadelphia: Elsevier Soundera; 2012.
27. Gartner LP, Hiatt JL. Color Textbook of:Histology. 3rd ed. Philadelphia: Saunders Elsevier; 2007.
28. Fail P a., Sloan CS, Johnson JD, Brown VJ. Final Detailed Review Paper on Steroidogenesis Screening Assays and Endocrine Disruptors. 2005;(68).
29. Handa RJ, Sharma D, Uht R. A Role for the Androgen Metabolite, 5alpha
Androstane 3beta, 17beta Diol (3β-Diol) in the Regulation of the Hypothalamo-Pituitary–Adrenal Axis. Front. Endocrinol. (Lausanne). 2011;2(November):1-10. doi:10.3389/fendo.2011.00065.
30. Sherwood L. Introduction to Human Physiology. 8th ed. Australia: Broks/cole; 2013.
31. Guyton AC, Hall JE. Buku Ajar Fisiologi Kedokteran. Jakarta: EGC; 1997.
32. Hess RA, Bunick D, Bahr J. Oestrogen , its receptors and function in the male reproductive tract — a review. 2001;178:29-38.
33. Abney TO. The potential roles of estrogens in regulating Leydig cell
development and function : A review. 1999;64:610-617.
34. Kerdivel G, Habauzit D, Pakdel F. Assessment and molecular actions of endocrine-disrupting chemicals that interfere with estrogen receptor pathways. Int. J. Endocrinol. 2013;2013. doi:10.1155/2013/501851.
35. Adams C, Bhandari a. Endocrine Disrupting Chemicals in the Environment. Pract. Period. Hazardous, Toxic, Radioact. Waste Manag. 2003;7:201-201. doi:10.1061/(ASCE)1090-025X(2003)7:4(201).
36. Diamanti E. Endocrine-Disrupting Chemicals:An Endocrine Society Scientific Statement. Endocr. Soc. 2009.
37. Schug TT, Janesick A, Blumberg B, Heindel JJ. Endocrine disrupting chemicals and disease susceptibility. J. Steroid Biochem. Mol. Biol. 2011;127(3-5):204-15. doi:10.1016/j.jsbmb.2011.08.007.
53
39. Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan. Pedoman Penggunaan Insektisida (Pestisida): Dalam Pengendalian Vektor. Jakarta: Kementria Kesehatan Republik Indonesia; 2012.
40. Aktar MW, Sengupta D, Chowdhury A. Impact of pesticides use in agriculture: their benefits and hazards. Interdiscip. Toxicol. 2009;2(1):1-12.
doi:10.2478/v10102-009-0001-7.
41. World Health Organization. WHO Specifications and Evaluations for Public Health pesticides:Transfluthrin.; 2003:1-15. Available at:
http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:WHO+speci fications+and+evaluations+for+public+health+pesticides#0.
42. Rapporteur Member State the Netherlands. Regulation (EU) n"528/2012 Concerning the Making Available on the Market and Use of Biocidal Products:Transfluthrin.; 2014.
43. California Environmental Protection Agency. Propoxur:Risk Characterization Document. Ann. ICRP 1997;39. doi:10.1016/j.icrp.2009.12.007.
44. United States Environmental Protection Agency. Reregistration Eligibility Decision ( RED ):Propoxur.; 1998:2-7. Available at:
http://linkinghub.elsevier.com/retrieve/pii/S0168649698000051.
45. Naughton CK, Nadler RB, Basler JW, Humphrey PA. Leydig cell hyperplasia. Britiish J. Urol. 1998;17:57-65.
46. Jeng HA. Exposure to endocrine disrupting chemicals and male reproductive health. Front. public Heal. 2014;2(June):55. doi:10.3389/fpubh.2014.00055.
47. Naughton CK, Nadler RB, Basler JW, Humphrey PA. Leydig Cell Hyperplasia. Britiish J. Urol. 1998;81:282-289.
48. McGlynn KA, Cook MB. The Epidemiology of Testicular Cancer. 1996;2. doi:10.1007/978-1-4419-0449-2.
